facebook

What Are the Stages of Diabetic Retinopathy?

TL;DR: Diabetic retinopathy progresses from mild changes needing monitoring to proliferative retinopathy, where fragile new blood vessels grow on the retina, the light-sensitive layer at the back of the eye, and can bleed. Swelling at the macula, the central part of the retina responsible for detailed vision, is graded separately because it can occur at any stage. The stage decides how often you are seen and whether you need treatment.

The stage is not a label. It is an instruction about how closely your eye needs watching.

blog-image-diabetic-retinopathy

The International Stages of Diabetic Retinopathy

An international grading scale describes five levels. Non-proliferative retinopathy means there is damage to existing retinal blood vessels but no abnormal new vessel growth. Proliferative retinopathy means abnormal new vessels have developed.¹

Stage
What the Eye Shows
What It Usually Means
No apparent retinopathy
No abnormalities
Routine screening
Mild non-proliferative
Microaneurysms, tiny bulges in weakened blood vessel walls, only
Routine screening
Moderate non-proliferative
More haemorrhages, small areas of bleeding, and vessel changes
Closer monitoring
Severe non-proliferative
Widespread bleeding, veins with a beaded appearance or abnormal vessels within the retina
Specialist care; high risk of progression
Proliferative
New vessels on the retina or optic nerve, which carries visual signals to the brain, or bleeding into the vitreous, the gel filling the eye
Treatment to prevent severe sight loss

The progression from damaged, leaking capillaries, the smallest blood vessels, to areas of retina without a blood supply, and then to new vessel growth, reflects the underlying disease process.¹

blog-image-mild-moderate-npdr
blog-image-severe-npdr-pdr

How the NHS Screening Programme Grades It

In England, screening uses a simpler grading system:²

Grade
What It Means
R0
No retinopathy
R1
Background retinopathy
R2
Pre-proliferative retinopathy, referred to an eye clinic
R3
Proliferative retinopathy, referred urgently
M1
Signs of maculopathy, damage affecting the central part of the retina, referred for assessment

Why the Stage Matters

Proliferative retinopathy. The Diabetic Retinopathy Study showed that laser treatment to the peripheral retina, the area outside the centre, reduces the risk of severe vision loss in high-risk proliferative disease by at least half.³ Anti-vascular endothelial growth factor (anti-VEGF) injections, medicines that block a signal involved in abnormal blood vessel growth and leakage, are now also used in selected cases.⁴

Macular oedema, swelling at the macula. The Early Treatment Diabetic Retinopathy Study showed that laser reduced moderate vision loss from macular oedema.⁵ Today, anti-VEGF injections are usually the first-line treatment when swelling involves the centre of the macula and affects vision; the decision depends on your vision and the full clinical findings, not on fluid on the scan alone.⁴

Can Retinopathy Go Backwards?

Early changes can stabilise, and sometimes improve, with better control of blood sugar and blood pressure. Advanced changes are less likely to reverse, which is why early detection and treatment matter.

Diabetic Retinopathy Stages in More Detail

Mild Non-Proliferative Retinopathy

The earliest visible change is the microaneurysm, a tiny bulge in a weakened capillary wall that looks like a red dot. Vision is unaffected. This is common in people who have had diabetes for some years, and it is a prompt to keep blood sugar and blood pressure on target rather than a cause for alarm.

Moderate Non-Proliferative Retinopathy

More vessels are damaged. Small haemorrhages, and sometimes yellow deposits called exudates, appear. Some capillaries begin to close. Vision is usually still normal unless the macula is involved, but monitoring becomes more frequent.

Severe Non-Proliferative Retinopathy

Large areas of retina are short of blood. Doctors look for haemorrhages across the retina, veins that look beaded and abnormal small vessels within the retina. At this stage, there is a risk of progressing to proliferative disease, so specialist care and close follow-up are essential.⁴

Proliferative Retinopathy

The oxygen-starved retina releases growth signals, and fragile new vessels grow on the retina or optic nerve. They can bleed into the vitreous gel, causing sudden floaters or loss of vision, and scar tissue can pull the retina away.¹

Treatment is needed promptly.

How Quickly Does Retinopathy Progress?

It varies considerably. Many people stay at mild stages for years, particularly with good control of blood sugar and blood pressure. Others progress faster, especially with long-standing or poorly controlled diabetes, kidney disease or during pregnancy. That is why the stage decides how soon you are seen again.

blog-image-oct-scan-1

Stage, Monitoring and Treatment at a Glance

Stage
Typical Approach
None or mild
Regular screening
Moderate
More frequent monitoring, often in an eye clinic
Severe non-proliferative
Close specialist review; treatment considered in selected cases
Proliferative
Laser and/or injections; surgery if bleeding or traction, where scar tissue pulls on the retina
Any stage with centre-involving macular oedema
Injections usually recommended when vision is affected

When to Seek Urgent Help

If you have diabetes and your eyesight suddenly gets worse or you develop blurred vision, ask for an urgent GP appointment or contact NHS 111. Do not wait for your next routine screening or clinic appointment.⁶

New floaters, dots or lines in your vision, also need checking. Contact your GP, diabetes care team or optician, and seek urgent help if they occur alongside sudden worsening of your sight.⁶

Frequently Asked Questions

Can I move back down a stage?

Early changes can improve with better control of diabetes and blood pressure. More advanced changes are less likely to reverse, but treatment can stabilise them.

Duration of diabetes matters too, as does blood pressure. Good control reduces risk substantially but cannot remove it entirely.

The stage alone does not determine whether you can drive. You must meet the required visual standards, and reduced vision or the effects of laser treatment may affect your eligibility.

You may need to notify the Driver and Vehicle Licensing Agency (DVLA), depending on your eye condition, treatment and whether one or both eyes are affected. Your consultant can advise, but notifying the DVLA when required is your responsibility. Do not drive if you do not meet the visual standards or have been told not to drive. Rules are stricter for bus and lorry drivers.⁷

Your consultant sets an interval based on your stage, the macula and how stable your eyes have been, and tells you what should prompt an earlier appointment.

At Blue Fin Vision®

At our eye clinic, we assess diabetic retinopathy with a full retinal examination and optical coherence tomography (OCT) imaging, a scan that produces detailed cross-sectional images of the retina. We explain what your stage means for monitoring and treatment.

If treatment is needed, our service is built around rapid access, with injections at our Harley Street clinic the same day or the following day and an organised next step with us or through the NHS.

These resources explain more about the condition and our service:

Further patient information is available through:

Understand your stage. Know your next steps. Book a consultation with Blue Fin Vision® for a consultant-led assessment and a personalised monitoring or treatment plan, with clinics in London, Hertfordshire & Essex.

References

  1. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677-82.
  2. Scanlon PH. The English National Screening Programme for diabetic retinopathy 2003-2016. Acta Diabetol. 2017;54(6):515-25.
  3. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology. 1981;88(7):583-600.
  4. National Institute for Health and Care Excellence. Diabetic retinopathy: management and monitoring. NICE guideline NG242. London: NICE; 2024.
  5. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103(12):1796-806.
  6. NHS. Diabetic retinopathy [Internet]. 2025 [cited 2026 Nov 8].
  7. Driver and Vehicle Licensing Agency. Eye conditions and driving: if you have a car or motorcycle licence [Internet]. GOV.UK [cited 2026 Nov 8].

ABOUT THE AUTHOR

Mr Mfazo Hove
MBChB MD FRCOphth CertLRS
Consultant Ophthalmic Surgeon | Founder and Medical Director, Blue Fin Vision®

Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with more than two decades of experience across NHS and private practice and more than 57,000 ophthalmic procedures performed. He trained for six and a half years at Moorfields Eye Hospital and served for five years as an NHS consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust.

He specialises in cataract surgery, refractive lens replacement, laser vision correction and implantable Collamer lenses (ICL). He is the founder and Medical Director of Blue Fin Vision®, a private ophthalmology group providing consultant-delivered care across London, Hertfordshire and Essex. His cataract surgery outcomes are publicly reported through the National Ophthalmology Database.

A ZEISS Key Opinion Leader and international speaker, Mr Hove is a contributing author to The Ophthalmologist and Ophthalmology Times. His writing examines how clinical governance and the organisation of ophthalmic services shape patients’ experiences and outcomes, with a focus on transparent outcome reporting, surgical training and long-term accountability for patient care.

Schedule Your Consultation Today

Latest Posts